This inventor holds 2 USPTO granted patents. Top assignee: Toyama Chemical Co., Ltd.. Active years: 1976-1984.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Toyama, JA (1976)
- Toyama, JP (1984)
Company Filing History:
Years Active: 1976-1984
Title: The Innovations of Tomonobu Yamaguchi
Introduction
Tomonobu Yamaguchi is a notable inventor based in Toyama, Japan. He has made significant contributions to the field of chemistry, particularly in the development of compounds with potential therapeutic applications. With a total of 2 patents, Yamaguchi's work focuses on innovative chemical derivatives that can serve as valuable agents in medical treatments.
Latest Patents
Yamaguchi's latest patents include the development of 5-Fluoro-(β-uridine or 2'-deoxy-β-uridine) derivatives. These compounds are designed to act as carcinostatic agents, which are crucial in cancer treatment. His work also encompasses novel sym-triazine carbamates, which exhibit central nerve inhibitory, anti-inflammatory, analgesic, and sedative activities. These compounds can be synthesized through specific chemical reactions, showcasing Yamaguchi's expertise in organic chemistry.
Career Highlights
Yamaguchi is associated with Toyama Chemical Co., Ltd., where he continues to innovate and contribute to the field. His research has led to advancements in the development of compounds that have significant medical applications. His dedication to his work is evident in the quality and impact of his inventions.
Collaborations
Yamaguchi collaborates with esteemed colleagues such as Tsutomu Kodama and Masaakira Senoura. These partnerships enhance the research and development process, allowing for a more comprehensive approach to innovation in their field.
Conclusion
Tomonobu Yamaguchi's contributions to chemistry and medicine through his patents reflect his commitment to advancing scientific knowledge and improving therapeutic options. His work continues to inspire future innovations in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile